Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Pune, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Nuclear Medicine Market Size & Growth Analysis: According to SNS Insider, The Global Nuclear Medicine Market size was valued at USD 11.1 billion in 2023...
-
WHITEHALL, Ohio, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Heartland BancCorp (“Heartland” and “the Company”) (OTCQX: HLAN), parent company of Heartland Bank (“Bank”), today reported net income increased...
-
Wilmington, Delaware, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Isotopes Market by Type (Stable, Unstable), by Application (Medical, Industrial,...
-
RAPPORT ANNUEL 2024 LOI ECKERT Au 13 janvier 2025 le CREDIT AGRICOLE D’ILLE-ET-VILAINE détient dans ses livres : 12 063 comptes inactifs pour un montant total de dépôts et avoirs de 7 334 992,56 €. ...
-
FARMINGDALE, N.Y, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced that it was notified by the New York Stock Exchange (the “NYSE”) that it...
-
Dublin, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The "Radiotherapy/Radiation Oncology Devices - Market Insights, Competitive Landscape, and Market Forecast -2030" report has been added to ...
-
SEATTLE, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
-
BERLIN, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Pentixapharm AG, a developer of innovative radiopharmaceuticals, receives 6.77 million Euro for intangible assets formerly developed by Glycotope from...
-
HAMPTON, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the Company has initiated a Phase 2 study of barzolvolimab in atopic dermatitis (AD)...
-
FARMINGDALE, N.Y., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fiscal first quarter ended October 31, 2024. ...